Riot Platforms has recently voiced strong opposition to Bitfarms’ adoption of the Poison Pill strategy. This plan effectively restricts any single entity from acquiring more than 15% of Bitfarms’ common shares without initiating a full takeover bid. Riot Platforms criticized this move as a demonstration of subpar corporate governance and a failure to prioritize shareholder